Cargando…
Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
BACKGROUND: Since the beginning of the novel coronavirus (SARS-CoV-2) disease outbreak, there has been an increasing interest in finding a potential therapeutic agent for the disease. Considering the matter of time, the computational methods of drug repurposing offer the best chance of selecting one...
Autores principales: | Mohamed, Kawthar, Yazdanpanah, Niloufar, Saghazadeh, Amene, Rezaei, Nima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676368/ https://www.ncbi.nlm.nih.gov/pubmed/33261845 http://dx.doi.org/10.1016/j.bioorg.2020.104490 |
Ejemplares similares
-
Cognitive Biases Affecting the Maintenance of COVID-19 Pandemic
por: Mohamed, Kawthar, et al.
Publicado: (2021) -
Loneliness: An Immunometabolic Syndrome
por: Pourriyahi, Homa, et al.
Publicado: (2021) -
Computed tomography scan in COVID-19: a systematic review and meta-analysis
por: Sharif, Pouya Mahdavi, et al.
Publicado: (2022) -
A systematic review of pregnant women with COVID-19 and their neonates
por: Mirbeyk, Mona, et al.
Publicado: (2021) -
Interleukin-6 and severe COVID-19: a systematic review and meta-analysis
por: Mojtabavi, Helia, et al.
Publicado: (2020)